PoliRNA
PoliRNA develops targeted RNA therapies through hybrid nanoparticles to regenerate the heart after myocardial infarction.
PoliRNA is a business in medtech.
The company sits in the medtech segment, where it competes on its core product or service.
Directory data places it at the I3P portfolio company stage.
| Sector | Medtech |
|---|---|
| Stage | I3P portfolio company |
Website: user-160435880-work.colibriwp.com/polirna
Browse related
Sign in to view the contact information we hold for PoliRNA.
Create a free account
Create a free account